Molecular and Cellular Characterization of Skull Base Tumors

RecruitingOBSERVATIONAL
Enrollment

4,000

Participants

Timeline

Start Date

October 3, 2018

Primary Completion Date

October 3, 2028

Study Completion Date

October 3, 2028

Conditions
Skull Base NeoplasmCellular Pathology
Interventions
OTHER

Observation

Understanding the biology of skull base tumors will teach the investigators about the genesis and/or mechanisms of treatment resistance. The investigators hope to ultimately identify new targets which will add to the armamentarium by which to treat these tumors.

Trial Locations (1)

15213

RECRUITING

University of Pittsburgh Medical Center, Pittsburgh

All Listed Sponsors
lead

University of Pittsburgh

OTHER